Glenmark receives ANDA approval for steroidal drug from US FDA
Glenmark Pharmaceuticals Inc., USA has been granted final approval by the US FDA for Estradiol Vaginal Inserts USP, 10 mcg, the generic version of Vagifem1, 10 mcg, of Novo Nordisk Inc.
According to IQVIA sales data for the 12-month period ending July 2018, the Novo Nordisk product achieved annual sales of approximately $286.3-mn.
Glenmark’s current portfolio consists of 139 products authorized for distribution in the US market and 61 ANDA’s pending approval with the US FDA. In addition to these internal filings, Glenmark continues to identify and explore external development partnerships to supplement and accelerate the growth of its existing pipeline and portfolio.
2026-09-04
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
关于加强防范钓鱼邮件的通知 Notification on Strengthening Anti-Phishing Measures
-
关于全面排查下架易制毒及易制爆产品信息的公告 Announcement on the Comprehensive Review and Removal of Product Information Related to Precursor and Explosive Precursor Chemicals
-
FDA Orders Removal of “Suicidality Warning”: Are Weight-Loss Blockbusters Finally Cleared—or Is Regulators Giving the Market a Reality Check?
-
The FDA Officially Blesses AI for Liver Drug Development
-
U.S. FDA Opens New Safety Review of RSV Treatments for Infants
-
A Fake Email Drains RMB 12 Million: Asia’s Waterproof Giant’s Overseas ‘Payment Heist’ Exposes the Fatal Blind Spot of Chinese Corporate Globalization
-
FDA Names Veteran Oncology Regulator Pazdur as Director of Drug Review Center
-
U.S. Delays Mandatory GRAS Notification Proposal, Pushing Food-Additive Overhaul to Year-End
-
South Korea and Japan Launch Energy Supply Chain Cooperation as Hormuz Risks Grow
-
The End of Hype: Europe’s Bio-stimulant Industry Faces a Science-First Reckoning by 2030
Recommend Reading
-
Japan Tightens the Rules—Then Loosens Them: A Surprising Shift in Food Additive Policy
-
Global Butadiene Market Faces Heavy Headwinds as Supply Surge Outpaces Demand
-
EPA Clears Backlog of Refinery Biofuel Waivers, Sparking Fears for Ethanol Demand
-
EU Biocidal Data Protection Extension Raises the Stakes for Chemical Market Entry
-
Four Fine Chemical Units of Huajin Aramco Project – HDPE, EO/EG, etc. – Reach Mechanical Completion
-
Both Cost and Demand Weaken, PTA Prices Slightly Decline
-
Supply and Demand Bearish, Toluene Market Declines
-
Weak Demand Weighs on Butadiene Market
-
Weak demand leads to a fluctuating decline in phthalic anhydride prices this week in China
-
October China Urea Market First Depressed Then Improved